Pluri, an established global leader in the development and manufacturing of cell-based therapeutics, launches new revenue-generating Contract Development and Manufacturing Organization (CDMO) division ...
DUBLIN--(BUSINESS WIRE)--The "Global Small Molecule Contract Development and Manufacturing Organization (CDMO) Market Growth Opportunities, 2023" report has been added to ResearchAndMarkets.com's ...
The "mRNA Therapeutics Contract Development & Manufacturing Organization Market Size, Share & Trends Analysis Report By Indication (Metabolic & Genetic Diseases), By Application, By End Use, By Region ...
As a biosecurity crackdown on certain Chinese pharma service providers gains momentum in Washington, the industry trade group Biotechnology Innovation Organization (BIO) is warning U.S. lawmakers that ...
DURHAM, N.C. & CARLSBAD, Calif.--(BUSINESS WIRE)--KBI Biopharma, Inc. (KBI), a JSR Life Sciences company and cGMP contract development and manufacturing organization (CDMO), and Argonaut Manufacturing ...
CHATHAM, N.J., March 20, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (TNXP) (Tonix or the Company), a biopharmaceutical company with marketed products and a pipeline of development ...
The "Contract Manufacturing of Medical Devices: Global Markets" report has been added to ResearchAndMarkets.com's offering. The global market for contract manufacturing of medical devices is estimated ...
Chinese life science contracting giant WuXi AppTec is taking another step to zero in on its core offerings by hiving off two China-based subsidiaries. The Shanghai-based corporation announced on Oct.
Contract manufacturers have carved out a lucrative niche within the biopharma industry, and the value of their collective capacity and production agility was on full display during the COVID-19 ...
Agno Pharma, a global contract development and manufacturing organization (CDMO) specializing in small-molecule active ...
Codexis Inc. and Axolabs have entered into an agreement under which Axolabs will evaluate Codexis’ ECO Synthesis Manufacturing Platform.
HAIFA, Israel, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Pluri Inc. (Nasdaq: PLUR) (TASE: PLUR) (“Pluri” or the “Company”), a leading biotech company that transforms cells into solutions that promote global ...